Skip to content Skip to navigation

Bold ideas to advance healthy brain aging win inaugural Knight Initiative grants

by Julia Diaz

The Phil and Penny Knight Initiative for Brain Resilience is proud to announce the recipients of its inaugural 2022 Innovation and Catalyst Grants.

These 17 groundbreaking research projects will receive a total of $15.5 million to pursue fresh ideas in the science of healthy brain aging and spearhead innovative methods of combating neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. 

“Together, these innovative proposals will pursue transformative ideas outside the mainstream that will advance our mission to extend the healthy lifespan of the human brain,” said Tony Wyss-Coray, PhD, the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences and Director of the Knight Initiative.

The projects are led by scientists from 12 departments across Stanford’s schools of Medicine, Engineering, and Humanities and Sciences, and include collaborators from an even wider range of disciplines. 

Photo of Tony Wyss-Coray

“We were looking for bold ideas that transcend the assumptions and biases of the field, and were delighted to receive nearly three dozen excellent applications from some of the best scientists at Stanford, many of whom come from disciplines outside the neurosciences and have never worked in neurodegeneration before.”
Tony Wyss-Coray
Director, Knight Initiative for Brain Resilience

Six research projects have been selected to receive $1.5 million, 3-year Innovation Grants based on their potential to lead to transformative discoveries in the areas of brain resilience and neurodegeneration.

Funded projects will pursue a wide range of approaches, including addressing the role of inflammation and the microbiome in aging and neurodegeneration, exploring how to therapeutically mimic the well-known brain benefits of exercise to promote healthy brain aging, and developing pioneering methods to fight neurodegeneration using engineered immune cells.

The initiative also awarded a new “Innovation 100 Grant” to a groundbreaking project that will leverage the initiative’s new Brain Resilience Laboratory to study the biology of brain resilience in a large cohort of cognitively healthy Costa Rican centenarians.

“People who live past the age of 90 with their cognitive functions intact may hold clues to promoting healthy brain aging for the rest of us,” said Wyss-Coray. “This study presents a unique opportunity to use the advanced research center we are building here at Stanford to understand these remarkable individuals.” 

Learn more about the Knight Initiative Innovation Grants program

Read about the launch of the Knight Initiative for Brain Resilience

Because of the extraordinary number of promising proposals, the initiative has also elected to fund an additional 10 projects with smaller Catalyst Grants — providing  $500,000 over 2 years to kickstart exciting and previously under-explored research directions. 

These projects include initiatives to employ machine learning to identify markers of resilience in the brains of older adults; explorations of the roles of endocannabinoids, cellular stress, and sleep circuits in brain aging; and efforts to develop new clinical tools for Parkinson’s disease, traumatic brain injury, ALS (Lou Gehrig’s disease) and more. 

Innovation Award recipients will be presenting their bold research proposals at the Knight Initiative’s inaugural Brain Resilience Symposium on January 12, 2023.

Registration for this half-day in-person-only event closes December 16.

Read on to learn more about our 2022 Innovation and Catalyst Grant recipients:

Innovation 100 Grant

Innovation 100 Grant
Lead Researcher(s): Michael Greicius, MD, MPH

Collaborator(s): Euan AshleyDavid RehkopfHua Tang

This project will study 500 older healthy Centenarians to uncover biological factors connected to brain resiliency. Researchers aim to identify gene and protein patterns that protect against age-related diseases like Alzheimer’s to find novel targets for drugs that mimic these natural protections.

Innovation Grants

Innovation Grants
Lead Researcher(s): Katrin Andreasson

Collaborator(s): Ivan Soltesz

This team will investigate whether a decline in intestinal immune cell metabolism drives age-related inflammation and cognitive decline. By replacing aged intestinal macrophages with metabolically healthy ones, they hope to develop a novel approach to enhance cognitive resilience.
Innovation Grants
Lead Researcher(s): Chris Garcia

Collaborator(s): Anne BrunetAmi Bhatt

Inflammation is a hallmark of brain aging, yet the source of inflammation in the old brain — and how to eliminate it — is unknown. This team aims to provide insight on how inflammation affects the aging brain that could potentially lead to the generation of new therapies to promote brain resilience.
Innovation Grants
Lead Researcher(s): Jonathan Z. Long

Collaborator(s): Thomas MontineSteven Banik

Exercise improves cognition and protects against age-associated neurodegenerative diseases, but further research is needed to understand exactly how this occurs. This project aims to pave the way for therapeutics that can capture the benefits of exercise for promoting brain resilience.
Innovation Grants
Lead Researcher(s): Siddhartha Jaiswal

Collaborator(s): Marius WernigJody HooperCaleb Lareau

This project aims to identify how mutant peripheral immune cells that invade the brain might actually reduce Alzheimer’s disease risk. The research will explore how to mimic these cells’ resilience-promoting effects to design new Alzheimer’s therapies.
Innovation Grants
Lead Researcher(s): Judith Frydman

Collaborator(s): Wah ChiuSerena Yeung

This team aims to define how and why protein production breaks down in aging cells, leading to disease. This research may lead to new diagnostic and therapeutic approaches against neurodegenerative diseases and potentially aging itself.
Innovation Grants
Lead Researcher(s): Aaron D. Gitler
This project will explore whether amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) result from immune cells attacking altered neurons. The team aims to pioneer the use of engineered immune cells as therapies for neurodegenerative disorders.

Catalyst Grants

Catalyst Grants
Lead Researcher(s): Ivan Soltesz

Collaborator(s): Katrin Andreasson

This team aims to discover whether the brain’s endocannabinoid system is dysregulated during aging, triggering inflammation via molecules called prostaglandins. If so, a drug that decouples these systems might restore a youthful brain state and rescue cognitive function.
Catalyst Grants
Lead Researcher(s): Thomas Sudhof

Collaborator(s): Axel Brunger

This team will explore the idea that neurotoxic protein aggregates seen in neurodegenerative disorders act at the synaptic connections between cells, and that resilience against these disorders may come from natural synapse-supporting factors that could be transformed into new forms of therapy.
Catalyst Grants
Lead Researcher(s): Julie Kauer
This team plans to study whether changes in neurons in the midbrain that regulate sleep, wakefulness, and immunity could contribute to aging and neurodegeneration. If successful, this information could rescue deficits in sleep and restore a normal immune profile.
Catalyst Grants
Lead Researcher(s): Kang Shen

Collaborator(s): Aaron Gitler

This team aims to define a network of genes that contribute to stress resistance in neurons and identify how it could be activated to enhance brain resilience and protect against neurodegenerative disease.
Catalyst Grants

Lead Researcher(s): Maya Kasowski
Collaborator(s): James ZouThomas MontineAnshul Kundaje

This team will study the brains of individuals who lived past ninety with their cognitive function intact, using advanced tissue imaging and computer science to understand mechanisms of resilience that could slow neurodegeneration and preserve brain health.
Catalyst Grants
Lead Researcher(s): Melanie Hayden Gephart

Collaborator(s): Karen Hirsch

This team aims to be the first to study the cellular and molecular impact of traumatic brain injury by studying genetic material in human cerebrospinal fluid. This will help clinicians and researchers ID markers of brain resilience after injury, and ultimately improve treatment for severe TBI.
Catalyst Grants
Lead Researcher(s): Michelle Odden

Collaborator(s): Marion BuckwalterJames Zou

This team proposes the first comprehensive study of how mitochondrial DNA is related to cognitive function and susceptibility to dementia in a diverse population of over 11,000 adults. The outcomes of this study will provide insight into possible racial disparities in brain health.
Catalyst Grants
Lead Researcher(s): Anne Brunet
Using new animal models such as the African killifish, this team aims to develop approaches to predict individual brain aging trajectories early in life based on behaviors that can be modulated to promote healthy memory, executive function and processing speed as well as counter dementia.
Catalyst Grants
Lead Researcher(s): Jun Ding

Collaborator(s): Mark SchnitzerWilliam Greenleaf

This team aims to better understand how Parkinson's disease attacks the brain's basic motor programs and to spawn novel therapies against the disease using gene-editing technology.
Catalyst Grants
Lead Researcher(s): Monther Abu-Remaileh

Collaborator(s): Scott Dixon

This team plans to map how age-related dysfunction of cellular waste disposal in lysosomes could lead to neurodegenerative diseases, potentially laying the foundation for a map of organelle function in the brain.